On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Boehringer Ingelheim Pharma GmbH &co KG's own share of each project, not the project's full budget.
- Horizon 2020€969k · 7 projects
- FP7 (2007 to 2013)€619k · 5 projects
- Horizon Europe€290k · 10 projects
Projects
22 EU-funded projects, newest first. Each links to the official record.
- PANDORAAssociated partner
Doctoral network on discovering pathomechanisms and novel drug optimization for AMD
Horizon Europe · 2026–2030 · Project on CORDIS ↗
- PFAROSAssociated partner
Driving Sustainable Innovation to Minimise PFAS in European Healthcare
Horizon Europe · 2026–2031 · Project on CORDIS ↗
- FORTIFYAssociated partner
FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE
Horizon Europe · 2026–2029 · Project on CORDIS ↗
- LipidBRIGHTAssociated partner
Lipids as promising BRidge between novel disease InsiGHts and improved Therapy
Horizon Europe · 2026–2030 · Project on CORDIS ↗
- WATERPartner
Doctoral Network on Interfacial Water in Membrane Transport
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€290ktheir share - RealiseDAssociated partner
Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases
Horizon Europe · 2025–2029 · Project on CORDIS ↗
- ENKOREAssociated partner
Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments
Horizon Europe · 2025–2028 · Project on CORDIS ↗
- PharmEcoAssociated partner
Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing
Horizon Europe · 2024–2030 · Project on CORDIS ↗
- NHPigAssociated partner
Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models
Horizon Europe · 2024–2029 · Project on CORDIS ↗
- VICT3RAssociated partner
Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
Horizon Europe · 2024–2028 · Project on CORDIS ↗
- INSPIREPartner
INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€253ktheir share - PROTONPartner
Proton transport and proton-coupled transport
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€253ktheir share - ENTRAINPartner
ENdoThelial macRophage Alliance In Neuroinflammation
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
- TICARDIOPartner
Thrombo-inflammation in cardiovascular disease
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
- EUROoCPartner
Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
- €464ktheir share
- eCHO SystemsPartner
Enhancing CHO by Mammalian Systems Biotechnology (eCHO systems)
Horizon 2020 · 2015–2018 · Project on CORDIS ↗
- DISCOPartner
From DISCOvery to products: A next generation pipeline for the sustainable generation of high-value plant products
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€48ktheir share - TS-EUROTRAINPartner
Interdisciplinary training network for Tourette Syndrome; structuring European Training capacities for neurodevelopmental disorders
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€249ktheir share - ALEXANDERPartner
Mucus Permeating Nanoparticulate Drug Delivery Systems
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€116ktheir share - TRANSPOLPartner
Transport and signalling in Polarized Cells
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
- NEURASYNCPartner
Academic-Industrial Training Network on Alpha-Synuclein-related Brain Diseases
FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗
€206ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Boehringer Ingelheim InternationalgmbhGermany · 8 shared projects
- Novo Nordisk A/SDenmark · 7 shared projects
- Astrazeneca UK LimitedUnited Kingdom · 6 shared projects
- Bayer AktiengesellschaftGermany · 6 shared projects
- Sanofi-Aventis Deutschland GmbHGermany · 6 shared projects
- Ucb BiopharmaBelgium · 6 shared projects
- Janssen Pharmaceutica NVBelgium · 5 shared projects
- Merck Kommanditgesellschaft Auf AktienGermany · 5 shared projects
- Novartis Pharma AGSwitzerland · 5 shared projects
- Glaxosmithkline Research & Development LimitedUnited Kingdom · 5 shared projects
- Merck Healthcare KgaaGermany · 5 shared projects
- Sanofi US Services Inc.United States · 5 shared projects
- Pfizer IncUnited States · 5 shared projects
- Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 4 shared projects
- Katholieke Universiteit LeuvenBelgium · 4 shared projects
- Universitaet BernSwitzerland · 4 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- RNA
- alzheimer
- animal and dairy science
- arteriosclerosis
- artificial intelligence
- big data
- biofuels
- biophysics
- cardiovascular diseases
- cell biology
- chemical sciences
- civil society
- colors
- computational intelligence
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
